T1D Exchange has built an innovative non-profit model that puts the community of people touched by type 1 diabetes (T1D) at the heart of scientific and clinical research.
Our partnership with you — the community — is resulting in more meaningful studies on unmet needs, faster delivery of therapies and devices and improved care.
One way we’re working together to improve care is by providing the necessary evidence to help people get better access to T1D devices and medications.
As much as we want payers to give people with type 1 better access to medications and devices for lower cost, we know they don’t make decisions based on the goodness of their hearts. They require “evidence” — data that shows that paying for a treatment will lead to better outcomes — which ultimately lowers their costs.
But while we want all people with T1D to have access to systems and devices, we can’t forget the basics.
More Test Strips!
T1D Exchange conducted a study that revealed a strong relationship between the number of times self-monitoring blood glucose testing was performed per day and improved HbA1c levels across a wide age range of children and adults. In short, we learned that the more you test, the lower the HbA1c. It might not sound like rocket science but still, this is the type of evidence insurers need when determining what’s covered in an insurance plan. If left up to insurers, they may only pay for 3 test strips per day — and every person with T1D knows it’s easy to blow through 2 test strips in one sitting to try and get an accurate result. That doesn’t leave you with many options when you need to test many times per day.
In fact, the data from our study has been used to help support insurance coverage for test strips in the state of Washington; who previously had only covered three per day for people with T1D. Today, it’s 10.
IMPACT: Evidence Leads to Access
At T1D Exchange, we are working across many initiatives and along with many other organizations to raise awareness for the challenges people affected by type 1 diabetes face in accessing affordable healthcare, treatment and supplies.
Thank you for being part of our community dedicated to making a real impact for all people with type 1 diabetes. Stay tuned as we’ll continue to keep you informed of opportunities to participate in research, share your stories and have your voice be heard.
Our data is robustly cited to inform regulators, insurers, clinicians and others in the healthcare ecosystem.
In particular, it’s this data that has been used to support insurance coverage for more test strips per day.